Volume 8, Issue 5, Pages (May 1998)

Slides:



Advertisements
Similar presentations
Fig. 3. Activation and Th1 differentiation of the P25 TCR-Tg CD4+ T cells after BCG lung infection. The N-P25 TCR-Tg mice were i.t.
Advertisements

Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Cyclophosphamide induces type I interferon and augments the number of CD44hi T lymphocytes in mice: implications for strategies of chemoimmunotherapy of.
Following the Development of a CD4 T Cell Response In Vivo
Initial T Cell Receptor Transgenic Cell Precursor Frequency Dictates Critical Aspects of the CD8+ T Cell Response to Infection  Vladimir P. Badovinac,
Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells by Wuding Zhou, Hetal Patel, Ke Li, Qi Peng, Marie-Bernadette.
Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients by Devi.
Volume 31, Issue 2, Pages (August 2009)
Volume 16, Issue 2, Pages (February 2002)
IL-33 dysregulates regulatory T cells and impairs established immunologic tolerance in the lungs  Chien-Chang Chen, PhD, Takao Kobayashi, PhD, Koji Iijima,
The Roles of Fas/APO-1 (CD95) and TNF in Antigen-Induced Programmed Cell Death in T Cell Receptor Transgenic Mice  Huey-Kang Sytwu, Roland S Liblau, Hugh.
Volume 31, Issue 5, Pages (November 2009)
David Voehringer, Kanade Shinkai, Richard M Locksley  Immunity 
Volume 26, Issue 1, Pages (January 2007)
by Ulrike Schleicher, Andrea Hesse, and Christian Bogdan
Monocyte-Derived Dendritic Cells Formed at the Infection Site Control the Induction of Protective T Helper 1 Responses against Leishmania  Beatriz León,
Volume 20, Issue 4, Pages (April 2004)
Volume 132, Issue 7, Pages (June 2007)
Volume 11, Issue 4, Pages (October 1999)
Volume 18, Issue 5, Pages (May 2003)
Volume 36, Issue 1, Pages (January 2012)
Volume 29, Issue 2, Pages (August 2008)
Kathleen R. Bartemes, BA, Gail M. Kephart, BS, Stephanie J
NKT Cells Inhibit the Onset of Diabetes by Impairing the Development of Pathogenic T Cells Specific for Pancreatic β Cells  Lucie Beaudoin, Véronique.
Volume 31, Issue 2, Pages (August 2009)
Distinct phases in recovery of reconstituted innate cellular-mediated immunity after murine syngeneic bone marrow transplantation  Jeffery J. Auletta,
Volume 123, Issue 4, Pages (October 2002)
Volume 15, Issue 4, Pages (October 2001)
Volume 28, Issue 3, Pages (March 2008)
Volume 29, Issue 5, Pages (November 2008)
Volume 13, Issue 6, Pages (November 2015)
Down-Regulation of IL-4 Gene Transcription and Control of Th2 Cell Differentiation by a Mechanism Involving NFAT1  Alexander Kiani, João P.B Viola, Andrew.
A Two-Step Process for Thymic Regulatory T Cell Development
Volume 31, Issue 5, Pages (November 2009)
Volume 81, Issue 4, Pages (February 2012)
Volume 13, Issue 6, Pages (December 2000)
Dynamics of Blood-Borne CD8 Memory T Cell Migration In Vivo
Volume 36, Issue 2, Pages (February 2012)
Volume 4, Issue 3, Pages (March 1996)
Volume 17, Issue 3, Pages (September 2002)
Volume 11, Issue 2, Pages (August 1999)
Volume 29, Issue 1, Pages (July 2008)
Volume 17, Issue 5, Pages (November 2002)
Volume 33, Issue 4, Pages (October 2010)
Volume 22, Issue 2, Pages (February 2005)
Volume 6, Issue 3, Pages (March 1997)
Marginal Zone and B1 B Cells Unite in the Early Response against T-Independent Blood-Borne Particulate Antigens  Flavius Martin, Alyce M Oliver, John.
Volume 28, Issue 4, Pages (April 2008)
Volume 32, Issue 5, Pages (May 2010)
Volume 33, Issue 3, Pages (September 2010)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
Volume 24, Issue 1, Pages (January 2006)
STAT3 Is Required for Flt3L-Dependent Dendritic Cell Differentiation
Intrathymic T Cell Development and Selection Proceeds Normally in the Absence of Glucocorticoid Receptor Signaling  Jared F Purton, Richard L Boyd, Timothy.
Cecile King, Alex Ilic, Kersten Koelsch, Nora Sarvetnick  Cell 
Volume 16, Issue 4, Pages (April 2002)
Volume 27, Issue 2, Pages (August 2007)
Volume 32, Issue 6, Pages (June 2010)
Volume 32, Issue 1, Pages (January 2010)
David Voehringer, Kanade Shinkai, Richard M Locksley  Immunity 
Volume 11, Issue 3, Pages (September 1999)
Volume 28, Issue 5, Pages (May 2008)
Volume 7, Issue 3, Pages (September 1997)
Volume 4, Issue 6, Pages (June 1996)
Volume 15, Issue 4, Pages (October 2001)
Volume 27, Issue 4, Pages (October 2007)
Volume 35, Issue 1, Pages (July 2011)
Dissecting the Multifactorial Causes of Immunodominance in Class I–Restricted T Cell Responses to Viruses  Weisan Chen, Luis C. Antón, Jack R. Bennink,
Volume 25, Issue 6, Pages (June 2017)
Volume 8, Issue 5, Pages (May 1998)
Presentation transcript:

Volume 8, Issue 5, Pages 591-599 (May 1998) Potent and Selective Stimulation of Memory-Phenotype CD8+ T Cells In Vivo by IL-15  Xiaohong Zhang, Siquan Sun, Inkyu Hwang, David F Tough, Jonathan Sprent  Immunity  Volume 8, Issue 5, Pages 591-599 (May 1998) DOI: 10.1016/S1074-7613(00)80564-6

Figure 1 Expression of IL-2 Receptor Subunits on T Cell Subsets Using three-color staining, pooled LN cells from normal mice were stained with mAbs specific for IL-2Rα, IL-2Rβ, or IL-2Rγ followed by mAbs specific for CD4, CD8, and CD44. Gated CD4+ or CD8+ cells were analyzed for IL-2Rα, β, or γ chain expression on CD44hi, CD44int, or CD44lo subpopulations. Immunity 1998 8, 591-599DOI: (10.1016/S1074-7613(00)80564-6)

Figure 2 IL-15 mRNA Expression in Macrophages Doses of 1 × 106 thioglycollate-elicited peritoneal macrophages from B6 mice were cultured in vitro in medium alone or with IFNα (1000 U/ml), IFNβ (5000 U/ml), IFNγ (1000 U/ml), Poly I:C (100 μg/ml), LPS (10 μg/ml), IL-12 (500 ng/ml), or IL-15 (100 ng/ml) for 4 hr. Total RNA was extracted and reverse transcriptase PCR was performed to amplify the mRNA levels of mouse IL-15 (365 bp) and G3PDH (496 bp). PCR products were visualized by ethidium bromide staining after electrophoresis on an agarose gel. Immunity 1998 8, 591-599DOI: (10.1016/S1074-7613(00)80564-6)

Figure 3 Effects of Cytokines on T Cell Proliferation In Vitro Purified populations of CD8+ or CD4+ cells were cultured in the presence of a fixed (A) or variable (B and C) concentration of the cytokines shown for various periods in the presence of BrdU (12.5 μg/ml). (A and B) After removal of dead cells by Ficoll gradients, cells were stained for surface markers and BrdU incorporation and analyzed by FACS. The data show percentage BrdU labeling of subsets of T cells expressing different levels of CD44 and IL-2Rβ. Cells were stained after 72 hr of culture in (A) and for 24 or 42 hr of culture in (B). The data in (A) and (B) are from different experiments. (C) Purified CD8+ or CD4+ cells (1.5 × 106/ml) were cultured with the indicated concentration of IL-2 or IL-15 for 72 hr; live cells were enumerated under the phase-contrast microscope and by FACS analysis on the basis of forward versus side scatter. The data show the fold increase in viable cells relative to the input number (C, top) and percentage of viable cells (C, bottom) at the end of the culture period. Immunity 1998 8, 591-599DOI: (10.1016/S1074-7613(00)80564-6)

Figure 4 Normal Turnover of CD4+ and CD8+ T Cells Expressing Different Levels of CD44 and IL-2Rβ Groups of ATx mice were given BrdU water continuously for various periods. Pooled LN cells from these mice were stained for CD4, CD8, CD44, and IL-2Rβ expression and then for BrdU incorporation. The data show the percentage BrdU labeling of subsets of CD8+ (A) and CD4+ (B) cells; each point represents the mean value for two mice per group. Dot plots show BrdU labeling of gated CD8+, CD8+ CD44hi, or CD4+ cells on days 1 and 30. Immunity 1998 8, 591-599DOI: (10.1016/S1074-7613(00)80564-6)

Figure 5 BrdU Incorporation by T Cell Subsets from Mice Injected with Poly I:C, IL-15, or IL-2 B6 mice were given BrdU drinking water continuously for 3 days after intravenous injection of PBS (control), IL-2 (40 μg/mouse), or IL-15 (2 μg/mouse) and intraperitoneal injection of Poly I:C (100 μg/mouse). Pooled LN cells were stained for CD4, CD8, CD44, and IL-2Rβ and then for BrdU incorporation, followed by FACS analysis. (A) BrdU incorporation by CD4+ and CD8+ cells expressing different levels of CD44 (top) and IL-2Rβ (middle) or CD44hi CD4+ and CD8+ subsets expressing different levels of IL-2Rβ (bottom). (B) The mean values for percentage BrdU labeling from four mice per group, derived from two different experiments. Immunity 1998 8, 591-599DOI: (10.1016/S1074-7613(00)80564-6)

Figure 6 A Comparison of the Capacity of IL-2 versus IL-15 to Cause Proliferation of Subsets of T Cells In Vivo Mice were given BrdU continuously in the drinking water for 3 days after intravenous injection of various doses of IL-2 or IL-15. Pooled LN cells were stained for surface markers and BrdU incorporation followed by FACS analysis as for Figure 5. The data show mean values from two mice per group. Immunity 1998 8, 591-599DOI: (10.1016/S1074-7613(00)80564-6)

Figure 7 Kinetics of T Cell Proliferation In Vivo after Injection of IL-2, IL-15, or Poly I:C (A) Mice were injected with PBS (control), IL-2 (40 μg/mouse), or IL-15 (2 μg/mouse) and immediately given BrdU in the drinking water for the time shown. LN cells were then removed and stained for surface markers and BrdU incorporation followed by FACS analysis. (B) Mice were injected with IL-2 or IL-15 (as for [A]) or with Poly I:C (100 μg/mouse). At various times thereafter, the mice received a single intraperitoneal injection of BrdU (1 mg/mouse) followed 4 hr later by staining for surface markers and BrdU incorporation. In (A) and (B), each point represents the mean data from two mice per group. Immunity 1998 8, 591-599DOI: (10.1016/S1074-7613(00)80564-6)